Cipla Q4 profit misses estimates as US market competition weighs
Cipla, India’s third-largest drugmaker by revenue, reported weaker-than-expected fourth-quarter earnings on Wednesday as weak sales and intense competition in its...
Read moreCipla, India’s third-largest drugmaker by revenue, reported weaker-than-expected fourth-quarter earnings on Wednesday as weak sales and intense competition in its...
Read moreEuropean companies are on track to report their strongest quarterly earnings growth in three years, driven largely by gains in...
Read moreSiemens reported weaker-than-expectedsecond-quarter earnings on Wednesday.The German engineering group posted strong order growth and maintained its full-year outlook despite what...
Read moreNebius stock will be in the spotlight today as the European technology giant publishes its financial results, which are expected...
Read moreGermany’s Allianz on Wednesday reported a 52% rise in first-quarter net profit, supported by gains linked to the sale of...
Read moreDisclaimer: Profitnewsreport.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company. Copyright © 2026 Profitnewsreport.com
Disclaimer: Profitnewsreport.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company. Copyright © 2026 Profitnewsreport.com